Bioline Rx reported $-1.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Arca Biopharma USD -31.82M 2.24M Mar/2026
Bio Path USD -270K 706K Mar/2026
Bioline Rx USD -1.6M 635K Mar/2026
Capricor Therapeutics USD -30.17M 5.6M Dec/2025